Hormonal Contraceptive Use and Breast Cancer in Thai Women

被引:8
作者
Poosari, Arisara [1 ]
Promthet, Supannee [1 ]
Kamsa-ard, Siriporn [2 ]
Suwanrungruang, Krittika [3 ]
Longkul, Jirapat [1 ]
Wiangnon, Surapon [4 ]
机构
[1] Khon Kaen Univ, Fac Publ Hlth, Dept Epidemiol, Khon Kaen 40002, Thailand
[2] Khon Kaen Univ, Fac Publ Hlth, Dept Biostat & Demog, Khon Kaen 40002, Thailand
[3] Khon Kaen Univ, Fac Med, Canc Unit, Khon Kaen 40002, Thailand
[4] Khon Kaen Univ, Fac Med, Dept Pediat, Khon Kaen 40002, Thailand
关键词
hormonal contraceptive; breast cancer; Thai women; ORAL-CONTRACEPTIVES; RISK; COHORT; HISTORY;
D O I
10.2188/jea.JE20130121
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Background: Breast cancer is the most common cancer in women worldwide. We investigated the association of hormonal contraceptive use and breast cancer in Thai women. Methods: A cohort study was conducted in Khon Kaen, Thailand. There were 70 cases of histologically confirmed breast cancer among 11 414 women aged 30 to 69 years who were recruited as participants in the cohort study during the period from 1990 through 2001. The study population was followed-up until December 31, 2011. To identify factors associated with incidence of breast cancer, hazard ratios (HRs) and 95% confidence intervals (CIs) were estimated using a Cox proportional hazards model. Results: The 11 414 women provided a total observation time of 157 200 person-years. Breast cancer risk among women with a history of hormonal contraceptive use was 1.31 times that of women without such a history, but the difference was not statistically significant (95% CI, 0.65-2.65). No type of hormonal contraceptive was associated with a significant increase in breast cancer risk as compared with women who had never used hormonal contraceptives (oral contraception: HR = 1.35, 95% CI, 0.65-2.78; injection contraception: HR = 1.25, 95% CI, 0.56-2.80), and there was no relationship between duration of hormonal contraceptive use and breast cancer. Conclusions: There was no association between hormonal contraceptive use and breast cancer; however, this finding should be viewed with caution due to the small number of cases.
引用
收藏
页码:216 / 220
页数:5
相关论文
共 26 条
  • [21] Absence of an effect of injectable and implantable progestin-only contraceptives on subsequent risk of breast cancer
    Strom, BL
    Berlin, JA
    Weber, AL
    Norman, SA
    Bernstein, L
    Burkman, RT
    Daling, JR
    Deapen, D
    Folger, SG
    Malone, KE
    Marchbanks, PA
    Simon, MS
    Ursin, G
    Weiss, LK
    Spirtas, R
    [J]. CONTRACEPTION, 2004, 69 (05) : 353 - 360
  • [22] Suwanrungruang K, 2011, ASIAN PAC J CANCER P, V12, P3283
  • [23] Suwanrungruang K, 2011, ASIAN PAC J CANCER P, V12, P173
  • [24] Oral, injected and implanted contraceptives and breast cancer risk among US Hispanic and non-Hispanic white women
    Sweeney, Carol
    Giuliano, Anna R.
    Baumgartner, Kathy B.
    Byers, Tim
    Herrick, Jennifer S.
    Edwards, Sandra L.
    Slattery, Martha L.
    [J]. INTERNATIONAL JOURNAL OF CANCER, 2007, 121 (11) : 2517 - 2523
  • [25] Weight loss and postmenopausal breast cancer in a prospective cohort of overweight and obese US women
    Teras, Lauren R.
    Goodman, Michael
    Patel, Alpa V.
    Diver, W. Ryan
    Flanders, W. Dana
    Feigelson, Heather Spencer
    [J]. CANCER CAUSES & CONTROL, 2011, 22 (04) : 573 - 579
  • [26] Injectable and Oral Contraceptive Use and Cancers of the Breast, Cervix, Ovary, and Endometrium in Black South African Women: Case-Control Study
    Urban, Margaret
    Banks, Emily
    Egger, Sam
    Canfell, Karen
    O'Connell, Dianne
    Beral, Valerie
    Sitas, Freddy
    [J]. PLOS MEDICINE, 2012, 9 (03)